Singson, Kyle Daniel C.

HRN: 22-33-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
AMPICILLIN 500MG (VIAL)
01/21/2023
01/28/2023
IVTT
180mg
Q6
PCAP
Waiting Final Action 
01/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2023
01/28/2023
IVTT
54mg
Q24
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: